UPLOAD Filing
aTYR PHARMA INC
Date: Aug. 13, 2025 · CIK: 0001339970 · Accession: 0000000000-25-008523
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289360
Letter
Re: aTyr Pharma, Inc. Registration Statement on Form S-3 Filed August 7, 2025 File No. 333-289360 Dear Sanjay Shukla:
August 13, 2025
Sanjay Shukla Chief Executive Officer aTyr Pharma, Inc. 10240 Sorrento Valley Road, Suite 300 San Diego, CA 92121
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Charles Bair, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 13, 2025 Sanjay Shukla Chief Executive Officer aTyr Pharma, Inc. 10240 Sorrento Valley Road, Suite 300 San Diego, CA 92121 Re: aTyr Pharma, Inc. Registration Statement on Form S-3 Filed August 7, 2025 File No. 333-289360 Dear Sanjay Shukla: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Charles Bair, Esq. </TEXT> </DOCUMENT>